Can medications help with cerebral palsy?
Medications don’t cure CP, but they can make a real, meaningful difference. Think of them as tools for easing symptoms like muscle stiffness, spasms, pain, drooling, or seizures. They help children move with less effort, feel more comfortable, and participate more fully in everyday life.
Several of these drugs have real evidence behind them rather than merely conventional use. A 2019 systematic overview that graded every cerebral palsy intervention published between 2012 and 2019 listed anticonvulsants, bisphosphonates, botulinum toxin, botulinum toxin combined with occupational therapy, botulinum toxin combined with casting, diazepam and intrathecal baclofen among the medical interventions with demonstrated effect. Medications can target muscle tone, improve posture, decrease discomfort, reduce seizure risk, and help with secondary issues like drooling or bladder control. Each child’s plan is personalized, often involving several medications at varying doses, adjusted over time as the child grows, their needs shift, and new options become available.
Medications work best as part of a coordinated plan alongside physical therapy, occupational therapy, speech therapy, and where needed, surgery. No medication replaces consistent therapy, but the right combination can make therapy significantly more effective.
The medications listed here require a prescription and should only be started, adjusted, or stopped under the guidance of your child’s physician or neurologist. Always consult your care team before making any changes to your child’s medication plan.
Five medication categories used to treat cerebral palsy
CP medications fall into five broad categories, each targeting a different set of symptoms. Most children use medications from more than one category, often in combination with therapy.
Children with CP often experience muscle or joint pain due to abnormal tone, positioning, or bracing. Over-the-counter medications manage mild to moderate pain; prescription options address more persistent discomfort. These can improve tolerance for therapy and reduce pain associated with muscle spasms.
Widely used to target specific muscles affected by spasticity. Botox temporarily weakens overactive muscles, reducing stiffness and improving range of motion. Effects typically last 3 to 6 months. Most effective when combined with physical therapy or bracing immediately after injection.
Oral and intrathecal muscle relaxants address generalized stiffness and spasticity throughout the body. Intrathecal baclofen pumps are particularly useful for severe spasticity that doesn’t respond to oral therapy, delivering medication directly to the spinal fluid for more targeted effect with lower systemic dosing.
I have been an ITB patient for 14 years, and I would definitely say it has been more effective than oral baclofen. It has allowed me to easily navigate and walk more independently. Although there are risks, it is something I strongly advocate for your child.
Prescribed to reduce drooling and control certain involuntary movements by blocking nerve signals that stimulate saliva glands and smooth muscle. An important quality-of-life medication for children with significant drooling, which can cause skin irritation and social challenges.
Epilepsy affects approximately 25% of children with CP, making anticonvulsants a critical part of management for many families. Medication choice depends on the seizure type, the child’s age, and tolerance for side effects. Some children require more than one anticonvulsant for effective control.
Quick-reference cerebral palsy medication list
These are the medications most often prescribed for cerebral palsy, by what they treat. Treat the list and the table below as a reference, and confirm current recommendations with your child’s care team, as prescribing practices evolve.
- Muscle relaxants for general stiffness: baclofen, diazepam, tizanidine and dantrolene
- Botulinum toxin type A (Botox) injections for stiffness in specific muscles
- Anti-seizure medicines for epilepsy: lamotrigine, topiramate, carbamazepine, phenytoin and zonisamide
- Anticholinergics for drooling and involuntary movements: glycopyrrolate, benztropine and trihexyphenidyl
- Pain relievers for mild to moderate pain: acetaminophen, ibuprofen and other NSAIDs
| Category | Common Medications | Primary Use |
|---|---|---|
| Pain Relievers | Acetaminophen, Ibuprofen, NSAIDs | Mild to moderate pain, muscle spasm discomfort |
| Botox Injections | Botulinum toxin type A | Focal spasticity in specific muscle groups |
| Muscle Relaxants | Baclofen, Diazepam, Tizanidine, Dantrolene | Generalized spasticity, muscle stiffness |
| Anticholinergics | Glycopyrrolate, Benztropine, Trihexyphenidyl | Drooling, involuntary movements |
| Anti-Seizure | Lamotrigine, Topiramate, Carbamazepine, Phenytoin, Zonisamide | Epilepsy / seizure control |
Which medication is prescribed for which symptom?
Your child’s prescription depends on their specific symptoms. The care team will recommend medications based on the type of CP (spastic, dyskinetic, athetoid) and how your child responds to therapy.
| Symptom | First-Line Medications | Notes |
|---|---|---|
| Focal spasticity | Botulinum toxin injections | Best for specific tight muscles; pair with PT immediately after |
| Generalized spasticity | Oral baclofen, Diazepam | Intrathecal baclofen pump if oral causes too much sedation |
| Involuntary movements | Trihexyphenidyl, Benztropine | Anticholinergics; monitor closely for side effects |
| Drooling | Glycopyrrolate, Scopolamine patch, Botox (salivary glands) | Botox injected into salivary glands is increasingly used |
| Seizures | Lamotrigine, Topiramate, Carbamazepine | Type of seizure determines drug choice; may require combination |
| Pain | Acetaminophen, Ibuprofen | Prescription options for persistent or severe pain |
Cerebral palsy medication side effects overview
No medication is without risk. Understanding the side effect profile of each drug helps families and care teams monitor for problems early and make informed decisions about the right balance of benefit versus risk.
A few principles govern how these drugs are started and monitored.
Almost everything here is started at a low dose and titrated upward against response and tolerance, which is why the first weeks rarely show the full effect. Dantrolene, tizanidine and the anticonvulsants need periodic blood work to check liver function or drug levels. Sedation is the side effect that most often undermines the plan, because several muscle relaxants and anticonvulsants cause drowsiness heavy enough to interfere with therapy participation, and the fix is usually timing rather than a different drug. New symptoms, behavioral changes and skin rashes after a start or a dose change should be reported the same week rather than at the next appointment. And nothing here should be stopped abruptly: baclofen and anticonvulsants in particular must be tapered under supervision, because abrupt withdrawal from baclofen can produce rebound spasticity, fever and, at the severe end, a life-threatening reaction. A pump that stops delivering is a medical emergency rather than a scheduling problem.
Many children with CP are on multiple medications simultaneously. A clinical pharmacist can review the full medication list for interactions, help manage side effects, and identify opportunities to simplify the regimen as the child grows.
Newest treatments on the horizon
While current medications primarily manage symptoms, exciting research is underway on potential approaches that may influence the underlying brain injury itself, offering hope beyond symptom control.
Umbilical cord blood cell therapy is the one on this list with the strongest footing, and it appears among the effective medical interventions in that same 2019 evidence review, having moved further than the broader stem cell field. Stem cell therapy more generally remains investigational, with neuroprotective and neuroregenerative effects demonstrated in models rather than established in practice, and it is not an FDA-approved treatment for cerebral palsy. Botulinum toxin injected into the salivary glands is increasingly used for drooling in place of oral anticholinergics, though a Cochrane review of drooling interventions covering six studies found the methodology too flawed across all of them to reach a conclusion on either approach. And cannabidiol continues to be researched for spasticity and for drug-resistant epilepsy, where state law and formulation both vary.
Ask your child’s neurologist or rehabilitation physician about clinical trial eligibility at clinicaltrials.gov.
How do medication needs change over time?
Children with CP require ongoing reassessment as they grow. Medication plans are not set-and-forget, they evolve continuously alongside the child’s development, therapy progress, and changing body.
Several things drive changes to a medication plan over the years.
Most of these drugs are dosed by body weight, so a plan that fit at four is underdosed at seven without anything else having changed. Progress in physical and occupational therapy can work the other way, letting a medication be reduced or dropped. Puberty shifts both spasticity patterns and seizure frequency, and usually forces a reassessment. School timing matters more than it sounds: doses are often rearranged specifically to keep sedation out of classroom hours while holding the therapeutic effect overnight. And the move to adult care frequently means different formulations and sometimes different drugs entirely, at exactly the point when continuity of care is hardest to maintain.
Regular evaluations with a pediatric neurologist, rehabilitation specialist, and pharmacist are essential. Families should view medication management as an ongoing collaborative conversation, not a fixed prescription.
CP medications can be expensive over a lifetime, especially injections and pumps. A birth injury legal claim can fund a lifetime of medication costs. Get a free case review to find out if your family qualifies.
Frequently asked questions about cerebral palsy medications
It depends on which symptom is most pressing rather than on a standard first-line list. For spasticity, baclofen, diazepam or botulinum toxin injections are the usual starting points, and a 2019 evidence review found demonstrated effect for all three. For seizures, the choice of anticonvulsant depends on seizure type, and this matters for a large share of the population: the CDC puts epilepsy in roughly 4 in 10 children with cerebral palsy. For drooling, anticholinergics or botulinum toxin into the salivary glands. For bone density, bisphosphonates.
There is no single best medication, and any source offering one is not describing cerebral palsy. The condition varies by type, by severity and by which associated problems are present, so the goal is the drug that targets this child’s dominant symptom with the fewest side effects at the lowest effective dose. Most children end up on medications from more than one category.
Yes, though the categories are largely the same. Dosing is by weight and therefore changes constantly through childhood. Selection shifts too: sedation that is tolerable in a preschooler may be unacceptable in a student, and adults often need different formulations. The transition from pediatric to adult care is where medication plans most often drift, because the coordinating clinician changes.
It varies enormously by category. Generic oral muscle relaxants and pain relievers are inexpensive. Botulinum toxin is the clearest example of a recurring cost: its effect on a treated muscle lasts roughly three to four months, so holding the benefit means repeating the injections two or three times a year indefinitely. Intrathecal baclofen pumps require surgical placement and periodic refilling. Both run into thousands of dollars a year. The pump also carries replacement costs and the risk of malfunction, which is a medical emergency rather than an inconvenience.
In most states Medicaid covers prescription medications for children with cerebral palsy, including muscle relaxants, anticonvulsants and anticholinergics. Coverage for botulinum toxin and for pump placement more often requires prior authorization and documented failure of less expensive options first. Medicaid waiver programs in many states cover items that standard plans decline, and eligibility for those is often based on the child rather than household income.
Substantially, and the plan should be treated as provisional rather than settled. Doses rise with body weight. Medications may come off entirely when therapy improves function. Puberty alters both tone and seizure frequency. And side effects that were acceptable at one age often are not at another, which is the most common reason a working drug gets changed.
